OpportunityTitle: Human Cell Reprogramming for Aging and Alzheimer&apos;s Disease Research (R21)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: The purpose of this FOA is to support the development of human induced pluripotent stem (iPS) cells and other reprogrammed cells for aging and Alzheimers disease modeling. The molecular and functional characterization of aged or Alzheimers disease phenotypes in specific cell types derived from human iPS and other reprogrammed cells is expected to provide proof-of-concept evidence that human reprogrammed cells can be valid cell models of aging and Alzheimers disease.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;